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Dinucleoside tetraphosphatase (Np4Nase; EC 3.6.1.17) has been purified 170 OOO-fold from a 306096 ammonium sulfate fraction of a human blood 
cell extract. Purification included a dye-ligand affinity elution step using the inhibitor adenosine S-tetraphosphate. Human blood Np4Nase resem- 
bled rat liver Np4Nase, including recognition by anti-rat NpilNase, but differed from homogeneous human leukemia Np4Nase in the lOOO-fold 
lower specific activity of the latter. The results are discussed in relation to the potential role of diadenosine tetraphosphate (Ap4A) in the control 
of cell division and the turnover of Ap4A in blood. 
Diadenosine tetraphosphate; Ap,A; Dinucleoside tetraphosphatase; Human blood 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Ap4A is a product, substrate or regulator of purine 
nucleotide metabolism, DNA replication and cell cycle, 
heat-shock response, and platelet aggregation (l-41. It 
is formed in reactions catalyzed by aminoacyl-tRNA 
synthetases [5,6], Ap4A-phosphorylase [7] and firefly 
luciferase [S]. ApJA turnover may be catalyzed by the 
intracellular Np4Nase [9] or the unspecific ectoenzyme 
phosphodiesterase Vnucleotide pyrophosphatase (EC 
3.1.4.1/EC 3.6.1.9) [IO], present also in plasma 1111. 
‘mammalian Np4Nase hydrolyzes specifically Np4Ns 
to the cognate nucleoside 5’-mono- and -triphosphates 
191. It has been purified to homogeneity from human 
leukemia cells [12] and rat liver 1131 with 0.02 and 145 
U/mg specific activities, respectively, which may reflect 
their molecular activities. Without data from normal 
human tissues, it is difficult to interpret the low effi- 
ciency of the leukemia enzyme. Here, we show that 
human blood cells contain Np4Nase which can be 
purified to a high specific activity, like the rat enzyme. 
Also, we have obtained an antibody recognizing human 
and rat Np4Nases. 
~bbrrvja~ions: Ap3A, diadenosine 5 ,5’ ’ I-Pt ,P’-triphosphate; 
Ap4A, diadenosine 5 ’ ,5’ ’ ’ -P’,@tetraphosphate; Np4N, 
dinucleoside 5 ’ ,5 ’ ’ ’ - P’,f%etraphosghate; Np4Nase. dinucleoside 
tetraphosphatase (EC 3.6.1.17) 
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(34) (24) 236304. 
Human blood (100 ml) collected over CPD-adenine anticoagulant 
(63 ml) (Terumo Corp.) was used. Blood cells were pelleted in a Sor- 
vail SS34 rotor (4 min at 4000 rpm and 4°C); resuspended in 130 ml 
50 mM Tris, pH 7.5; freeze-thawed at - 20°C; homogenized and cen- 
trifuged again, now at 15 000 rpm for 2 h. The supernatant was frac- 
tionated with ammonium sulfate; the 30-60% saturation fraction, 
dissolved in SO mM Tris, pH 7.5,O.Z mM EDTA (final volume 73 ml), 
was frozen at - 20°C in 6-ml aliquots until used for the purification 
of Np4Nase. 
The chromatograpl~ic procedures for the purification of blood 
Np4Nase were as described by Costas et al. [13] except that: Sephades 
G-100 filtration and DEAE-cellulose chromatography were carried 
out in 1.2 x 90-cm and 2.2 x 6-cm columns, respectively; in the af- 
finity elution chromatography, glycerol was not used. 
Anti-rat NpdNase was obtained from a rabbit immunized with four 
20.fig subcutaneous doses of rat liver Np4Nase. The enzyme was cut 
out from an SDS-PAGE gel after visualization with KC1 [13] and 
homogenized in complete (1st dose; day 0) or incomplete Freund’s ad- 
juvant (2nd-4th doses; days 24, 53 and 83). The rabbit was bled on 
day> 0 (control serum) and on day 97. Anti-Np4Nase titer was assayed 
by E!LISA as in [14] with minor modifications: 1 ng rat livjer Np4Nase 
was spotted onto nitrocellulose filters; the blocking agent was 1% 
gelatin; Tris substituted for phosphate in buffers; the second antibody 
was peroxidase-labeled goat anti-rabbit IgG (Sigma). Anti-Np4Nase 
titer was higher than I : 10000. 
Except when indicated, other materials and methods were as 
described in [13]. 
3. RESULTS 
The key to the purification of human blood cell 
Np4Nase to a high specific activity (Table I) was its elu- 
tion from a dye-ligand affinity column with the in- 
hibitor adenosine 5 ‘-tetraphosphate. The final specific 
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Table 1 
Purification of human blood NplNasc 
Step Specific 
L’olume Protein Acti\it\i acTi\ ir\ 
(ml) (mg) ( 111 u ) (mu 1&, 
30-604’0 ammonium sulfate 
fractionalion 12 2840 320 0.11 
SephadcM-100 se1 filtration 76 580 270 0.38 
DEAE-cellulose ion exchange 60 1 .x I50 83 
Cibacron blue I.3GA Scpharow 48 
affinity elution 6.5 0.004 78 I8500 
.Augu,t 1991 
I’ield 
(“‘0) 
IO0 
68 
4: 
24 
The puritication started from Iwo 6.ml porrions of a 3O-6O”b ammonium \ulfatc fraction of a frecte- 
and-thaw extract of blood cell, (see section 2). Those two pal-tions \cer-e separateI> procrswd rhrough 
steps l-3 (the results reported in the table are a combinnrion of dars from both pul-ificailor ~run\); rhe 
I-esulting material wa\, pooled and submiltcd to 5tcp 4. Protein and acti\il! were n\ra!ed :I\ in 1131. 
activity was 18.5 U/mg, 170 OOO-fold higher than the 
starting fraction (Table I). Silver-stained SDS-PAGE 
and immunoblot with anti-rat Np4Nase showed one 
I8-kDa band like that shown by rat liver Np4Nase (Fig. 
1). The latter has Np4Nase activity after renaturation 
[131. 
The K,,, value of human blood Np4Nase for Ap4A 
was 0.7 JIM (Fig. 2), determined by analysis of complete 
reaction progress curves [ 151. Np4Nase required Mg2 + 
as it had no activity in its absence. Maximal activity was 
found with 3-10 mM MgClz; 75V0, 50% and 2OVo of 
maximal activity was observed with 1 mM, 0.5 mM and 
0.2 mM MgC12, respectively (not shown). 
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Fig. I. Gel electrophoresis of Np4Nasz. Left panel: silver-stained 
SDS-PAGE (15% acrylamide) analysis of human blood Np4Nase. 
The bands near the 66 kDa marker may correspond 10 known artifact, 
[47]. (A) 14 pg enzyme from the DEAE-ccllulore step; (B) 0.15 rg 
from rhe affinity elution step (Table I). Kixhr panel: immunoblot of 
(C,D) rat liver and (E,F) human blood Np4Naw. Afrer SDS-PAGE 
(12.5’% acrylamide) proteins Ncre elecrl-o-transferred IO a 
nitrocellulose membrane which wa5 rhen processed by EI ISA ai 
described in section 2. Pre-immune serum gave no signal in a control 
immunoblot. (C) 11 pg from the DEAE-cellulose step in [13]; (D) 0.7 
kg of homogeneous rat Np4Nase [13]; (E) 120 g from the DEAE- 
cellulose step (Table I); (F) 0.15 ~(p from Ihc affinity elution step 
Fig. 2. Saturation kinerlcr of human blood NpNasc. K,,, = 0.7 PM; 
C’ - 0.7 nmolimin. Sarul-ation cur\c and parameters \\ers derived bq 
analy,ia and computer fitting of reaction progrehf cur\es [ 151 record- 
ed, at 37°C. followinp Ihe hyperchromwity at 259 nm caused by rhe 
hydrollsir of .Ap4A [5.X]. Completion of ApIA hydroly\i, \\as en- 
cured b\ ins irrever,ibilit! and by the coupl~ny 10 albalinc 
phosphatase, which prebcnts rhc accumulatloll of reaction products 
ATP and AXlP. The reaction \\a\ iniliarcd b! Ihe addition of 10 ALAI 
Ap4.A to a mixlure containing 50 mhl Tri+HU, pH 7.5. 5 m%l 
MgCIz, 10 g alkaline phospharare, and JO ng purified blood 
Np4Nase. At Ihe end of rhe first progress curve, a second one was 
Irecorded b> repeating the addition of ApJA: the results (nor shov,n) 
were wperm~posablr 10 those dcl-i\ed from Ihe fil-st progre\a curxe 
(we the figure). Thi\ indicarcs Ihat neither enzyme inactivation nor 
product inhibition inrerfcred in the dercl-lnillation of uturalion 
(-Table I). paramclers [I-5]. 
Several known Np4Nase inhibitors were tested with 
the blood enzyme. (i) Adenosine 5’-tetraphosphate in- 
hibits rat liver Np4Nase competitively with a 48 nM Ki 
value [9]. It also inhibited potently blood Np4Nase 
since, at 2 &l concentration, with 45 FM Ap4A as the 
substrate, it elicited a 42 I 3Vo inhibition. This, and the 
0.7 FM K,,, value, correspond to a 42 nM competitive Ki 
value. (ii) Zn’+ , at micromolar concentrations, inhibits 
rat liver Np4Nase [ 161. Fig. 3 shows a 5OVo inhibition of 
blood Np4Nase by 10 FM Zn’ + Under similar condi- 
tions, rat liver Np4Nasc is 5OVo inhibited by 2 PM Zn’+ 
[16]. (iii) Fluoride inhibits Np4Nase (0.S mM Ap4A as 
the substrate) from yellow lupin seeds (50% inhibition 
by 2-3 PM NaF) and beef liver (50% inhibition by 20 
FM NaF) [17]. We have studied the effect of NaF on 
human blood and rat liver Np4Nases (45 ,&I Ap4A as 
//2-;“‘1 
I 
3 6 
ApiA, FM 
86 
the substrate): Wr?n inhibition was caused by 80 $Vl and 
45 PM NaF, respectively (Fig. 3). 
4. DISCUSSKIN 
The high specific activity of purified, human Hood 
Np4Nase (Table I) confirms that the reportedly hamo- 
geneous, human leukemia Np4Nase is relatively very in- 
efficient because its specific activity is lOOO-fold lower 
[i2]. This could favor high Ap4A levels in leukemia 
cells: a possibitily se&ted tD the hypothesis thsr: Rp4A 
migl?t irave a rote in DNA synthesis an&or cell pro- 
Wxation II ,Lj], Ap4A is a grimer %-i\r DNA polymesase- 
a {18-B] and a tigand of a polymerize-associated pxx+ 
tein [f&21]. Evidence concerning the relationship be- 
tween Ap4A levels and the rate of cell proliferation OT 
the initiation of S-phase DNA replication is contrsdic- 
tory: some results Favor a direct relationship [XLZ’7]; 
others do not [2&323. The effect of Ap4A might be cell 
type-dependent. In this regard, Np4Nase from mouse 
ascites tumor cells may be different to leukemia 
Np4Nase, because the former, after a partial purifica- 
tion equivalent to the first three steps of Table f, shows 
z specific activity af a.3 Uimg 133f, Ix* 3-fofd highrr 
than biood NpctNase at the same ie& of ~~~r~f~ca~~~~~ 
<x-&&e I) and 2W%d higher &an horno~~~~o~~ 
Ieukemia Np4Nase 1 t Z] . 
Ap4A and its homologue Ap3A have affects on 
blood and vascular functions. They are stored in blood 
platelets and released upon thrombin-induced aggrcga- 
tion [34-361. Ap3A is pro-aggregatory, whereas Ap4A 
inhibits aggregation [3S] and is a potential anti-thrcrm- 
botic agent [37], Ap4A and Ap3A have vasomotrx ac- 
tivity and effects nn hepatic cell functions [38,39], The 
zLxEover of plasma Ap3A and A$_&% may be carried out 
by ciW&xing $1 f ,@-4Z] and ~ci~en~yma~~c ~~,~~~44~ 
hydrofases. Circuiating Ap4AC(Ap3A)-hydrolases %x? 
related to the uaspecifk phosphodiesterase f/nucleotide 
pyrophosphatase, an enzyme studied with dinucleoside 
polyphosphate substrates in rat liver IlO], and we& 
known itself as an ecrtcvenzyme in hepatocytes and other 
cells [45,46]. ApilA(Apl3A)-hydrolase eetoenzyme ac- 
tivity in endothelial celIs f43,44] probably aiso belor@s 
to that class of unspecific etrqmes. Np4TVase must not 
be confused with those n~s~ec~f~c A~4A-b~d~~~a~es 
that may act, on plasma Ati. but are ffot specific far 
d~n~c~~#s~~e t~~~~~s~~at~s~ The specific Np4Nasc Es 
seemin& an ~~~t~a~~~~u~ar enzyme, which makes 
unclear, aithough does not rufe out, its cofitribution lo 
the turnover of plasma Ap4A. 
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